No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study.

Nora V Butta,Elena G Arias-Salgado,Elena Monzón Manzano,Paula Acuña,María Teresa Álvarez Román,Antonio Buño-Soto,Juan Carlos Ramos Ramos,Cristóbal Belda-Iniesta,Jesús Frías,Antonio J Carcas,Lucía Martínez de Soto,Rosa de Miguel Buckley,David Lora,María Teresa García-Morales,Alberto M Borobia,José Ramón Arribas,Víctor Jiménez Yuste

Research and practice in thrombosis and haemostasis（2023）

引用 0|浏览13

暂无评分

摘要

Our data suggest that the heterologous vaccination against COVID-19 with ChAdOx1-S and a second dose with BNT162b2 might be safe in terms of haemostasis.

查看译文

关键词

COVID-19 vaccine,CombiVacS study,anti-PF4 antibodies,coagulation,hemostasis,heterologous vaccination,thrombocytopenia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要